These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8807116)
21. Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Goldman FD; Gilman AL; Hollenback C; Kato RM; Premack BA; Rawlings DJ Blood; 2000 Jun; 95(11):3460-6. PubMed ID: 10828029 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes. Contassot E; Robinet E; Angonin R; Laithier V; Bittencourt M; Pavy JJ; Cahn JY; Hervé P; Tiberghien P Bone Marrow Transplant; 1998 Dec; 22(11):1097-102. PubMed ID: 9877273 [TBL] [Abstract][Full Text] [Related]
23. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Rahim R; Strobl JS Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707 [TBL] [Abstract][Full Text] [Related]
24. The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease. Schultz KR; Gilman AL Leuk Lymphoma; 1997 Jan; 24(3-4):201-10. PubMed ID: 9156650 [TBL] [Abstract][Full Text] [Related]
25. Effect of methylxanthine derivatives on T cell activation. Singer JW; Bianco JA; Takahashi G; Simrell C; Petersen J; Andrews DF Bone Marrow Transplant; 1992 Jul; 10(1):19-25. PubMed ID: 1355384 [TBL] [Abstract][Full Text] [Related]
26. The pathophysiology of acute graft-versus-host disease. Jaksch M; Mattsson J Scand J Immunol; 2005 May; 61(5):398-409. PubMed ID: 15882431 [TBL] [Abstract][Full Text] [Related]
27. Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent. Emami J; Gerstein HC; Pasutto FM; Jamali F Can J Physiol Pharmacol; 1999 Feb; 77(2):118-23. PubMed ID: 10535702 [TBL] [Abstract][Full Text] [Related]
28. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model. Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study. In 't Veld AE; Grievink HW; van der Plas JL; Eveleens Maarse BC; van Kraaij SJW; Woutman TD; Schoonakker M; Klarenbeek NB; de Kam ML; Kamerling IMC; Jansen MAA; Moerland M Immunol Res; 2023 Aug; 71(4):617-627. PubMed ID: 36811819 [TBL] [Abstract][Full Text] [Related]
30. Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines. Abdel-Hamid AA; El-Firgany Ael-D J Mol Histol; 2016 Apr; 47(2):183-93. PubMed ID: 26872459 [TBL] [Abstract][Full Text] [Related]
31. Prevention of crystalline silica-induced inflammation by the anti-malarial hydroxychloroquine. Burmeister R; Rhoderick JF; Holian A Inhal Toxicol; 2019 Jun; 31(7):274-284. PubMed ID: 31556748 [No Abstract] [Full Text] [Related]
32. Hydroxychloroquine induces autophagic cell death of human dermal fibroblasts: implications for treating fibrotic skin diseases. Oikarinen A J Invest Dermatol; 2009 Oct; 129(10):2333-5. PubMed ID: 19749781 [TBL] [Abstract][Full Text] [Related]
33. Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cells. Kim ML; Hardy MY; Edgington-Mitchell LE; Ramarathinam SH; Chung SZ; Russell AK; Currie I; Sleebs BE; Purcell AW; Tye-Din JA; Wicks IP iScience; 2021 Dec; 24(12):103509. PubMed ID: 34934928 [TBL] [Abstract][Full Text] [Related]
34. Research progress of hydroxychloroquine and autophagy inhibitors on cancer. Shi TT; Yu XX; Yan LJ; Xiao HT Cancer Chemother Pharmacol; 2017 Feb; 79(2):287-294. PubMed ID: 27889812 [TBL] [Abstract][Full Text] [Related]
35. Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease. Shukla AM; Bose C; Karaduta OK; Apostolov EO; Kaushal GP; Fahmi T; Segal MS; Shah SV PLoS One; 2015; 10(9):e0139226. PubMed ID: 26414017 [TBL] [Abstract][Full Text] [Related]
37. Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review. Scott RE; Greenwood SL; Hayes DJL; Baker BC; Jones RL; Heazell AEP Reprod Toxicol; 2019 Aug; 87():50-59. PubMed ID: 31082466 [TBL] [Abstract][Full Text] [Related]
38. Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency? Renard P; Caccavelli L; Legendre A; Tuchmann-Durand C; Balakirouchenane D; Blanchet B; Narjoz C; Straube M; Hubas A; Garros A; Mention K; Bednarek N; Goudin N; Broissand C; Schlatter J; Cisternino S; Cagnard N; van Endert P; Diana J; de Calbiac H; de Lonlay P Biomed Pharmacother; 2023 Jul; 163():114813. PubMed ID: 37150031 [TBL] [Abstract][Full Text] [Related]
39. Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production Wabitsch S; McCallen JD; Ma C; Greten TF STAR Protoc; 2021 Jun; 2(2):100517. PubMed ID: 34013212 [TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Fox RI Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):82-91. PubMed ID: 8278823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]